ReviewCancers2024

De-Escalating Treatment Strategies for Patients with Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Early-Stage Breast Cancer.

Hikmat Abdel-RazeqPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.